Gilteritinib-induced pyoderma gangrenosum in a patient with acute myeloid leukemia: A case report

• Jonathan Sisley, BS,
• Mallory deCampos-Stairiker, BS,
• Sarah L. Becker, BA,
• Shannon K. Throckmorton, MD,
• Ronan Swords, MD, PhD,
• Alex G. Ortega-Loayza, MD, MCR

Affiliations

Jonathan Sisley, BS

Oregon Health & Science University School of Medicine, Portland, Oregon

Mallory deCampos-Stairiker, BS

Oregon Health & Science University School of Medicine, Portland, Oregon

Sarah L. Becker, BA

Oregon Health & Science University School of Medicine, Portland, Oregon

Shannon K. Throckmorton, MD

Oregon Health & Science University Department of Dermatology, Portland, Oregon

Ronan Swords, MD, PhD

Oregon Health & Science University Department of Hematology/Medical Oncology, Portland, Oregon

Alex G. Ortega-Loayza, MD, MCR

Oregon Health & Science University Department of Dermatology, Portland, Oregon; Correspondence to: Alex G. Ortega-Loayza, MD, MCR, Department of Dermatology, Oregon Health & Science University, 3303 S Bond Ave Building 1, 16th Floor, Portland, OR 97239.